Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nifedipine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel dual-catalyst method reduces genotoxic impurities in nifedipine intermediates, offering cost-effective scale-up for API manufacturers.
Patent CN114213318A details a novel DES-based synthesis for dihydropyridines, offering high purity, solvent recyclability, and significant cost reduction in pharmaceutical intermediate manufacturing.